Effects of Freund's complete adjuvant on the diurnal rhythms of neuroendocrine processes and ornithine decarboxylase activity in various tissues of male rats

Experientia

Volumn 52, Issue 9, 1996, Pages 900-908

  Neidhart, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diurnal rhythms; Freund's complete adjuvant; Ornithine decarboxylase; Prolactin

Indexed keywords

BROMOCRIPTINE; CORTICOSTERONE; FREUND ADJUVANT; GROWTH HORMONE; LUTEINIZING HORMONE; ORNITHINE DECARBOXYLASE; PARAFFIN; PROLACTIN;

ADRENAL CORTEX; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HYPOPHYSIS; HYPOTHALAMUS; KIDNEY; LIVER; LUTEINIZING HORMONE BLOOD LEVEL; LYMPHOID TISSUE; MALE; MICROCAPSULE; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS; PROLACTIN BLOOD LEVEL; RAT; TESTIS;

ANIMALIA;

EID: 0029833966     PISSN: 00144754     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01938878     Document Type: Article

References (32)

1. Wilder R. L. (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immun. 13: 307-338
2. Neidhart M. (1996) Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J. Rheumatol. 23: 476-481
3. Neidhart M. (1989) Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats. Endocrinology 125: 2846-2852
4. Neidhart M. and Larson D. F. (1990) Freund's complete adjuvant induced ornithine decarboxylase activity in the central nervous system of male rats and triggered the release of pituitary hormones. J. Neuroimmun. 26: 97-105
5. Neidhart M. and Flückiger E. W. (1992) Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77: 449-455
6. Russell, D. H. (1985) Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab. Rev. 16: 1-88
7. Scott, I. G., PÖsö H., Akerman K. E. O. and Andersson L. C. (1985) Rapid activation of ornithine decarboxylase by mitogenic (but not by nonmitogenic) ligands in human T lymphocytes. Fur. J. Immun. 15: 783-787
8. Poston G. J., Saydjari R., Lawrence J. P., Trudel J. L., Rubin N. H., Townsend C. M. Jr. and Thompson J. C. (1993) Persistence of the circadian variation and altered response to hepatectomy of hepatic ornithine decarboxylase activity with malignant tumor burden. Cancer Invest. 11: 400-407
9. Langlois A. and Morisset J. (1991) Effects of feeding, fasting, and caerulein treatment on ornithine decarboxylase in rat pancreas. Pancreas 6: 534-541
10. Rillema J. A. (1985) Prolactin stimulation of ornithine decarboxylase activity in the mammary gland may involve an activation of protein kinase C. Proc. Soc. Exp. Biol. Med. 178: 490-494
11. de Las Heras, M. A. and Calandra R. S. (1992) Acute effect of prolactin on ornithine decarboxylase activity in the rat testis. Arch. Androl. 29: 271-279
12. Gonzalez S. I., Suescun M. O., Rulli S. B., Estivariz F. and Calandra R. S. (1994) Modulation of ornithine decarboxylase activity by prolactin in seminal vesicles of the rat. Int. J. Androl. 17: 143-148
13. Crowe P. D., Buckley A. R., Zorn N. E. and Rui H. (1991) Prolactin activates protein kinase C and stimulates growth-related gene expression in rat liver. Mol. Cell. Endocrinol. 79: 29-35
14. Brelje T. C., Parsons J. A. and Sorenson R. L. (1994) Regulation of islet beta-cell proliferation by prolactin in rat islets. Diabetes 43: 263-273
15. Russell D. H., Kibler R., Matrisian L., Larson D. F., Poulos B. and Magun B. E. (1985) Prolactin receptors on rat lymphoid tissues and on human T- and B-lymphocytes: antagonism of prolactin binding by cyclosporine. In: Prolactin: Basic and Clinical Correlates, pp. 375-384. MacLeod R. M., Scapagnini U. and Thorner M. O. (eds), Springer Verlag, Berlin
16. Yu-Lee L. Y. (1990) Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol. Cell. Endocrinol. 68: 21-28
17. Van Arman C. G. (1976) Pathway to adjuvant arthritis. Fed. Proc. 35: 2442-2446
18. Bartlett R. R. and Schleyerbach R. (1985) Immunopharmacological profile of a novel isoxazol derivative. HWA 486, with potential antirheumatic activity. I. Disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharmacol. 7: 7-18
19. Murphy W. J., Rui H. and Longo D. L. (1995) Effects of growth hormone and prolactin immune development and function. Life Sci. 57: 1-14
20. Berczi I. and Nagy E. (1982) A possible role of prolactin in adjuvant arthritis. Arthritis Rheumatol. 25: 591-594
21. Cincotta A. H., Kinsely T. L., Landry R. J., Miers W. R., Gutierrez P. J., Esperanza P. and Meier A. H. (1995) The immunoregulatory effects of prolactin in mice are time of day dependent. Endocrinology 136: 2163-2171
22. Feige J. J., Madani C. and Chambaz E. M. (1986) Hormonal control of polyamine levels in bovine adrenoeortical cells. Endocrinology 118: 1059-1066
23. Maurer R. A. (1981) Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294: 94-97.
24. Crozat A., Palvimo J. J., Julkunen M. and Janne O. A. (1992) Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology 130: 1131-1144
25. Strumpfer A., Hsiao J., Peng T. and Richards J. (1992) Effect of lithium chloride on ornithine decarboxylase activity in rat adrenal. Can. J. Physiol. Pharmacol 70: 1293-1296
26. Koh C. Y. and Phillips J. T. (1993) Prolactin receptor expression by lymphoid tissues in normal and immunized rats. Mol. Cell. Endocrinol 92: R21-R25.
27. Nagano M. and Kelly P. A. (1994) Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J. Biol. Chem 269: 13337-13345
28. Badamchian M., Spangelo B. L., Damavandy T., MacLeod R. M. and Goldstein A. L. (1991) Complete amino acid sequence analysis of a peptide isolated from the thymus that enhances release of growth hormone and prolactin. Endocrinology 128: 1580-1588
29. Arkins S., Dantzer R. and Kelley K. W. (1993) Somatolactogens, somatomedins and immunity. J. Dairy Sci. 76: 2437-2450
30. Stevens A. M. and Lee L. Y. (1994) Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol. Endocrin. 8: 345-355
31. Tsai S. C. and Heppner G. H. (1994) Immunoendocrine mechanisms in mammary tumor progression: direct prolactin modulation of peripheral and preneoplastic hyperplastic-alveolar-nodule-infiltrating lymphocytes. Cancer Immunol. Immunother. 39: 291-298
32. Stephanou A., Sarlis N. J., Knight R. A., Lightman S. L. and Chowdrey H. S. (1992) Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNAs during adjuvant-induced arthritis in the rat. J. Mol. Endocrinol. 9: 273-281